Investor Presentation - Q&A update

RNS Number : 9000E

Omega Diagnostics Group PLC

11 November 2020

 

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

Investor presentation - Q&A Update

Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance testing, announces that a recording of the online Company presentation, which was delivered live by Colin King, Chief Executive, and Kieron Harbinson, Group Finance Director on 28 October 2020 at 4:30pm GMT, surrounding the Company's previously announced Trading Update, is now available to watch back on the Investor Meet Company platform. The Q&A has also been published following the meeting.

Investors can sign up to Investor Meet Company for free and add to meet Omega Diagnostics Group plc via the following link, which will take you to the recording of the presentation and the Q&A:

  https://www.investormeetcompany.com/omega-diagnostics-group-plc/register-investor

No new price-sensitive information is disclosed as part of the presentation. Within the presentation the Company provides indicative guidance on timelines for product evaluations, product supply, potential timing for first commercial sales and targeted production volumes. These timelines are for guidance purposes only and there is no guarantee that these will be met. The Company expects to keep shareholders updated regularly on progress in achieving these future milestones.

Contacts: 

Omega Diagnostics Group PLC	Tel: [phone]
Bill Rhodes, Interim Non-Executive Chairman Colin King, Chief Executive	www.omegadiagnostics.com
Kieron Harbinson, Group Finance Director
finnCap Ltd	Tel: [phone]
Geoff Nash/Edward Whiley (Corporate Finance)
Alice Lane (ECM)
Walbrook PR Limited	Tel: [phone] or [e-mail]
Paul McManus	Mob: [phone]
Lianne Cawthorne	Mob: [phone]

 

END

 

 

MSCDBLFFBFLEFBK